Page 14 - ITPS-8-3
        P. 14
     INNOSC Theranostics and
            Pharmacological Sciences                                                      AI in medical device safety
            development, approval, and oversight of AI technologies   through advanced data collection, real-time monitoring,
            and medical devices in the European Union. 58      and proactive risk detection. However, the implementation
              Nowadays, AI is increasingly being incorporated into   of AI in health care comes with significant challenges,
            medical devices. In Japan, the “Improvement Design within   including ethical concerns, regulatory requirements, and
            Approval for Timely Evaluation and Notice” (IDATEN)   technological limitations. Addressing these challenges
            system was introduced in September 2020 to streamline   necessitates a comprehensive approach, guided by
            the approval process for medical devices, particularly   collaborative efforts among technologists, medical
            Software as a Medical Device (SaMD) that utilizes AI.   professionals, regulators, and ethicists. To maximize AI’s
            Conventionally, any modifications to approved medical   benefits, the health-care industry must prioritize ongoing
            devices require a comprehensive review, which could be   research,  robust  regulations,  professional  training,  and
            time-consuming.  The IDATEN  system  allows  for partial   a human-centered approach that complements clinical
            modifications to be approved more swiftly, facilitating   expertise. This coordinated strategy will ensure that
            continuous improvements throughout a product’s lifecycle.   AI-driven materiovigilance enhances, rather than replaces,
            This feature is particularly advantageous for AI-based   human judgment, ultimately advancing health-care safety
            SaMD, which may require frequent updates to enhance   and efficacy.
            performance. 59
                                                               Acknowledgments
              The full potential of AI in health-care requires
            addressing four key ethical issues: algorithmic biases and   None.
            fairness,  safety  and  transparency,  consent  to  use  data   Funding
                                               55
            with patient information, and data privacy.  One major
            concern with AI-enabled materiovigilance systems is legal   None.
            accountability. As these systems become more autonomous,
            the question of who is responsible for errors or regulatory   Conflict of interest
            violations becomes more complex. The challenges AI poses   The authors declare they have no competing interests.
            in monitoring medical devices may require modifications
            to current legal frameworks, including data protection laws   Author contributions
            and liability statutes.  In addition, materiovigilance must   Conceptualization: Shubhima Grover
                            60
            adhere to ethical guidelines that prioritize transparency,   Visualization: Hara Prasad Mishra, Shubhima Grover
            fairness, and the protection of patient privacy when   Writing–original draft: Kevil Loriya, Nupur Shah, Hara
            utilizing AI. 61,62
                                                                  Prasad Mishra
              A comprehensive strategy is essential for addressing   Writing–review & editing: All authors
            these complex issues effectively. This strategy should
            involve the development of explicit regulatory guidelines,   Ethics approval and consent to participate
            the enhancement of transparency programs, and the   Not applicable.
            establishment of accountability frameworks. 27,58  To
            ensure responsible AI application in materiovigilance,   Consent for publication
            ethicists, policymakers, technology developers, and legal
            professionals must collaborate closely.  Furthermore,   Not applicable.
                                             63
            ongoing research and open dialog are essential for   Availability of data
            staying up to date with emerging ethical concerns
            and ensuring  the ethical  use  of AI  technologies  in   Not applicable.
            materiovigilance. 54,64  By fostering a balanced framework
            that prioritizes patient safety, privacy rights, and ethical AI   References
            development, stakeholders can maximize the benefits of   1.   Meher BR. Materiovigilance: An Indian perspective. Perspect
            AI in materiovigilance while reducing potential risks and   Clin Res. 2018;9(4):175-178.
            maintaining public trust in the health-care system. 61,62,65     doi: 10.4103/picr.PICR_26_18
            6. Conclusion: The future of AI in health-         2.   Raju N, Deivigarajan S, Santhakumar S, Balamurugan S.
            care vigilance                                        Knowledge, attitude and practice of materiovigilance among
                                                                  nurses and healthcare technicians in a tertiary care hospital:
            AI has the potential to revolutionize health care, particularly   A questionnaire-based survey. Open Access Res J Biol Pharm.
            materiovigilance, by improving patient safety and outcomes   2023;9(1):38-44.
            Volume 8 Issue 3 (2025)                         8                                doi: 10.36922/itps.6204





